2016年3月30日星期三

The Rank Prize Winner Lu Mingying’s Story of Seeking Treatment at Guangzhou Fuda Cancer Hospital

On March 16, a special patient attended at Guangzhou Fuda Cancer Hospital Press Conference. It’s Chinese British Scientist Dr. Lu Mingying, the Rank Prize winner.

Last month, she accepted nanoknife therapy at Guangzhou Fuda Cancer Hospital, and she was able to walk in the next day.

Dr. Niu Lizhi and Ms. Lu

In the end of 1980s, digital camera was very expensive, which cost several thousand dollars on the international market. Because the imaging sensor used in digital camera was costly at that time. In 1987 and 1989, Wang Guoyu and his wife Lu Mingying joined in experimental group of Edinburgh University in UK. With two professors of Edinburgh University tried to find a new imaging senor. After research, they succeeded in applying common CMOS in imaging sensor. It’s obvious that the innovation brought out so much benefit. The cost of imaging sensor fell by a third, which could put into mass production. Therefore, taking photo with mobile phone also turned to be easy. The cost of camera chip in mobile phone reduced to four dollars dramatically. Phone equipped with camera was not longer luxury but ordinary consumer item. Therefore, they were awarded top prize in the field of science—the Rank Prize. The technique was firstly applied in Nokia mobile phone. “It produces four million camera chips of mobile phones everyday in the world, which is connected with our technique.” Lu Mingying said.

The Rank Prize is one of the top awards in the field of British science, which is regarded as the Nobel Prize in the field of photoelectron and nutrition. The award goes to those who make innovation and contribution to human society in photoelectron and nutrition in the world. Just a few Chinese won this prize, like the Father of Hybrid Rice Yuan Longping and the Father of Optical Fibre Gao Kun.

Lu Mingying felt uncomfortable when she gave lecture at Kunming not long ago, and she was diagnosed as cholangiocarcinoma in local hospital. Her life encountered disaster.

At first, she chose to back Britain for treatment. She once asked help form Prof. Leen of Imperial College Medical School, a world-renowned oncologist specialized at nanoknife ablation therapy.

She could enjoy free treatment in Britain, but she had to wait. And there was no comprehensive therapy at local hospital. Her condition turned worse quickly, so she decided to go to China for treatment.

After transferring to several hospitals, she went to a cancer hospital which just offered chemotherapy and radiation. She didn’t accept chemotherapy. And she went to hospital at Beijing for consultation. They suggested to have chemotherapy firstly, then to have nanoknife therapy. She still didn’t want to have chemotherapy.

She decided to have the new technique -- nanoknife therapy. “I followed the word ‘nanoknife’ and searched in the internet. Finally, I found Guangzhou Fuda Cancer Hospital. I learnt that FUDA have done more than 70 case of nanoknife surgery by several phone consultations. I thought their technique was mature and determined to Guangzhou Fuda Cancer Hospital to have nanoknife ablation therapy.”

President Dr. Niu Lizhi said, “She suffered from abdominal pain and couldn’t walk when she first came to FUDA.”

She first had photodynamic therapy. On February 2, Lu Mingying had nanoknife therapy at Fuda Cancer Hospital. After four day, on February 6, she became better obviously. She could walk and get up to have a photo with President Niu Lizhi in the ward.

Then, she had comprehensive intervention therapy.

A few days ago, in the ward, Lu Mingying’s husband Wang Guoyu told the author that what they appreciated was the advanced technique for cancer treatment around the world, so they chose FUDA. And he disclosed that they were developing more advanced technique of multi-media digital broadcast which would be used in Beijing Road Walking Street.

2016年3月22日星期二

Photodynamic Therapy Shows Magic in Treating Esophageal Cancer Patient

In February 23, 2016, Mr. Wu who is from Inner Mongolia came to Guangzhou Fuda Cancer Hospital for re-examination in company of his son. Learning that the result of re-examination was normal, he hold the hands of his attending doctor Xing Yanli with eyes filling with tears and said, “Doctor Xing, thank you very much. And I also want to thank Doctor Li Hongmei. Thank Fuda Cancer Hospital. There are not only excellent medical skills but also satisfactory service. ”

Mr.Wu(Right)and Doctor Xing’s photo
Mr.Wu is 64 years old, who had been manager of a factory for more than 20 years. He wanted to enjoy the pleasures after retirement. Unexpectedly, he was diagnosed as esophageal cancer with lymph metastasis last year. Mr. Wu’s son was eager to save him and hoped him recover soon. They took Mr. Wu to Beijing for seeking treatment, but the answers all were “surgical removal”. Mr. Wu was afraid of the risk of surgery and hoped to find a mini-invasive treatment plan. His two sons were searching around effective treatments. And they learned that Guangzhou Fuda Cancer Hospital had special cancer treatment mode which met the aspiration of Mr. Wu. Therefore, they decided to have a try at Guangzhou. 

On August 21, 2015, Mr. Wu came to Guangzhou Fuda Cancer Hospital in company of his son. Chief president Xu Kecheng visited him, which made him surprised. Mr. Wu said, “President Xu was so approachable. He joked with me that he was 75 years old which was 11 years older than me, and he also was a cancer patient. I should be confident because they can help. After hearing these words, I felt a load off my mind.”

Learning that Mr.Wu hoped to be treated with mini-invasive treatment, President Xu held a consultation with experts right away. And they decided to adopt photodynamic therapy in treating Mr. Wu.

In fact, there are not a few patients like Mr. Wu who afraid of surgery in clinic. Besides traditional surgery, radiation and chemotherapy, Guangzhou Fuda Cancer Hospital has “3C+P” personalized therapy which including photodynamic therapy. Cancer photodynamic therapy kills cancer cells efficiently by photosensitizer and laser. And it’s mini-invasive treatment.

At the end of August and October, 2015, Mr. Wu accepted esophageal cancer photodynamic therapy twice. On 7 September, he accepted iodine 125 implantation in cardiac lymph nodes. And the surgery was successful. After surgery, Mr. Wu recovered well. Attending Doctor Xing Yanli said, “After having treatments several times, Mr. Wu was better and he just needed to do regular visits.” 

On February 23 of this year, Mr. Wu came back FUDA for re-examination. And all condition was normal. His son said sincerely, “Thank Fuda Cancer Hospital. And I hope Guangzhou Fuda Cancer Hospital can set a branch at Inner Mangolia for the benefit of local patients.” On February 25, Mr. Wu and his son set foot on the way home.
Mr. Wu (R) and his son gave Fuda Cancer Hospital a thumbs-up.


2016年3月8日星期二

Pancreatic Cancer Patient’s Life Being Rescued by Nanoknife Therapy at Guangzhou Fuda Cancer Hospital

On 29th February 2016, sunshine drove away the gloomy and the dark. After having nanoknife (irreversible electroporation) therapy, Mr. Qiu was going to leave hospital with heat full of hope. Looking back on the eight months of fighting against carcinoma of pancreatic head, he was filled with emotion. When Xu Kecheng, chief president of Guangzhou Fuda Cancer Hospital visited him, Mr. Qiu said sincerely: Thank you for making me not afraid of cancer anymore. I am confident to get back to health, because I receive correct treatment here.
 

Chief president Xu Kecheng (left) was visiting Mr. Qiu.


Mr. Qiu was thanking Doctor Shi Hongxia (middle).
 
Confront with carcinoma of pancreatic head
 
Mr. Qiu comes from Hong Kong. He is a 65-year old man with a pair gleaming eyes. He sat in front of me with a smile on his face. No one will think he is a cancer patient who has held on to fight against carcinoma of pancreatic head for 2800 days and nights.

Dr. Niu Lizhi, president of Guangzhou Fuda Cancer Hospital said that carcinoma of pancreatic head is malignant tumor. Eight months ago, Mr. Qiu was overwhelmed with sadness by the diagnosis.

Mr. Qiu once worked for a grand theatre. He has a filial daughter. He should have enjoyed the happiness of family. Unfortunately, on July 2015, Mr. Qiu found himself becoming thin and losing 10 kilograms without cause while suffering from abdominal pain. Mr. Qiu didn’t pay attention on it. After two months, he had diarrhea three to five times a day on average. On 11th November, he went to local hospital for examination without company of family.

After examination, Mr. Qiu was diagnosed as carcinoma of pancreatic head. PET-CT shown that was a 6.5 cm * 4.4 cm lump. Mr. Qiu said, he was so sad and shocked for knowing that carcinoma of pancreatic head is hard to treat, which made him felt death was approaching him.

Doctor of Hong Kong thought it took big risks having whipple surgery (pancreas duodenectomy) and advised Mr. Qiu to take biliary stent and bypass surgery. But Mr. Qiu refused. After taking chemotherapy twice, abdomen MRI scan showed the lump on pancreatic head reduced to 4.6 cm *3.9 cm. However, after having chemotherapy, he developed red rushes, itching, myelosuppression and hair loss etc. Chemotherapy was so painful that Mr. Qiu was urgent to find a suitable treatment plan.

I found proper treatment here luckily.

“Fortunately, when I failed in seeking treatment, my daughter took part in the lecture delivered by Mufeng, vice president of Guangzhou Fuda Cancer Hospital. She learnt about the most advanced ablation technique nanoknife therapy (irreversible electroporation) which can ablate targeted tumors and apply to pancreatic cancer. My intuition told me that Guangzhou Fuda Cancer Hospital will be my savior.”

On 17th February, Mr. Qiu was admitted to Guangzhou Fuda Cancer Hospital with being diagnosed as cT4N1M0 stage Ⅲ of carcinoma of pancreatic head. Soon, president Niu made a rigorous treatment plan for Mr. Qiu. It’s irreversible electroporation (nanoknife therapy) for carcinoma of pancreatic head treatment. On 23rd February, the operation was conducted smoothly and patient’s blood loss was just 2ml.

For more understanding of Guangzhou Fuda Cancer Hospital and the successful completion of nanoknife surgery, Mr. Qiu began to see hope. Remind of the period of having chemotherapy, I was often weak and tired at that time. But after nanoknife surgery, my psychological condition became better, and I became happier gradually. Mr. Qiu’s daughter said: “After nanoknife surgery, my father was better obviously. His psychological condition was improved. The confidence and encouragement of fighting against cancer were boosted.”

Mr. Qiu said, it’s unfortunate to have carcinoma of pancreatic head, but I was lucky to have advanced nanoknife therapy with good therapeutic effects in the fight against cancer. And he was said emotionally: “I sincerely appreciate Guangzhou Fuda Cancer Hospital. Thanks Dr. Niu Lizhi for performing operation for me. I also want to thank Doctor Shi Hongxia and nurses. The medical condition and environment are satisfactory and comfortable.”

In the afternoon of 29th February, chief president Xu Kecheng, Doctor Shi Hongxia and other medical workers visited Mr. Chou for he was going to leave. He expressed his gratitude again: I will come to have re-examination. It’s you who teach me to never give up at any time.
 

Photo of Mr. Qiu (middle), President Niu Lizhi (No.3 from right) and treatment team

2016年3月2日星期三

Rus’s story Kidney cancer with bone metastasis-Philippines

One year ago, at a seminar in Manila, Philippines, a fifty-year-old lady suddenly came to Prof. Xu Kecheng, her face was familiar, but Prof. Xu could not recall which kind of cancer she had(Figure 9). She said, “Professor Xu, you are my great benefactor, do you think that I am still sick?” I recognized that she was a patient with metastatic renal carcinoma, her name was Rus. Five years ago she had surgery. Three years ago, the patient came to our hospital with bone metastasis. For this kind of progressive renal cancer, chemotherapy and radiotherapy do not work at all. There are ten reports showing that patients with a 5-year survival rate vary from 0-13%. Prof. Xu treated her with Combined Immunotherapy for Cancer (CIC), which she unexpectedly greatly benefited from. Prof. Xu read her latest CT films done in the Philippines and no lesions could be seen. She gave Prof. Xu  two beer bottles with flowers that she herself had painted on as gifts. According to her family's custom, these flowers on beer bottle represent their cordial respects and gratitude. She was afraid Prof. Xu would not accept them, saying that she was too poor to send him valuables, she also did not dare send him valuables as she knew there is a rule in our hospital that all staffs are not allowed to accept gifts from patients. These were not valuables, but a token of her regards, so Prof. Xu accepted. Although Prof. Xu cannot fully understand the true meaning of the painting, he brought back these two beer bottles and put them on the bookcase in his office where he can see them everyday.

On November 19, 2011, the vice president Mr. Binay made an appointment with Prof. Xu in Manila. Mrs. Rus heard that Mr. Binay wanted to meet Prof. Xu, she came to the hotel that he stayed in early that morning, following Prof. Xu to go to the Vice Presidential Palace. Mr. Binay was very excited after listening to Prof. Xu’s presentation and had his photo taken with Mrs. Rus and her sister.

Several years have passed, Rus is still alive and healthy. Every time Professor Xu goes to the Philippines, she always accompanies him, and shares her anti-cancer experience with those cancer patients who still live in great misery.

 
Rus is sharing her personal anti-cancer experience with others

Vice President of the Philippines Binay received Ms. Rus(Left) and her younger sister

Rus is sharing her cancer rehabilitation experience as a volunteer of Fuda


Rus

Kidney cancer with bone metastases

Female, 58 years old, kidney cancer, nephrectomy with recurrent bone metastases.  After she received combined immunotherapy, the metastatic lesion disappeared. She has cancer-free survived for 6 years.

Treatment Experience

Those patients with metastatic kidney cancer who have undergone surgery, chemotherapy and radiotherapy have poor prognosis and their median survival period is less than one year. However, this patient has disease-free survived for 6 years, for which is closely related to immunotherapy.

Cancer cell is heterogeneous, which means cancer gene expression varies and it is very unstable during the differentiation. In other words, cancer cells change day by day. Immunotherapy shall be powerful and adaptable to fight cancer. The immunological measures used shall vary with cancer cells. 

Based on the above understanding, Fuda Cancer Hospital combine a variety of immunological measures, which is so-called combined immunotherapy (CIC), including CIK, DC, T cell transfusion therapy, cytokines injection and non-specific immunostimulating therapy. This would be like fighting a battle, the Army, Navy, Air Force, and even the police (immune cells and cytokines), intelligence agent (DC cells) are indispensable. For immune cells, it shall not only increase their number, but also take measures (non-specific therapy) to stimulate their enthusiasm, so that they dare to make a frontal attack on cancer cells. Of course, in some patients, before they receive one or more immunological measures, some special pre-tests shall be carried out to understand individual differences, on which personalized treatment will be made.

According to Rus’s specific condition, she was recommended to undergo CIC long-term non-specific immune therapy, focusing on mobilizing the initiative of innate anti-cancer ability to inhibit or even eliminate cancer cells (apoptosis), so she manage to obtain long-term survival. It is a great success, which can be called a miracle!

Treatment Team

Xu Kecheng   Professor
Chen Jibing    M.D.
Niu Lizhi    M.D.
Mu Feng    M.D.

Media Reports

Xu Kecheng: Follow Me to Fight Against Cancer,Beijing, People's Medical Publishing House

Videos

Combined Immunotherapy for Cancer